Jan 2, 2009 | MediLexicon
X-GEN Pharmaceuticals Receives FDA Approval For AcetaZOLAMIDE For Injection USP
Main Category: Cardiovascular / Cardiology Also Included In: Regulatory Affairs / Drug Approvals X-GEN Pharmaceuticals announced that it will begin marketing Acetazolamide for Injection USP.
X-GEN gets FDA nod to market AcetaZOLAMIDE for Injection USP
The product is AP rated and equivalent to Diamox by Duramed Pharmaceuticals. AcetaZOLAMIDE for Injection USP is indicated for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; ...
X-GEN Pharmaceuticals Receives FDA Approval for AcetaZOLAMIDE for Injection USP
The product is AP rated and equivalent to Diamox by Duramed Pharmaceuticals. Acetazolamide for Injection USP is indicated for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; ...